Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06560125 · ClinicalTrials.gov registry record
WOUNDCHEK Bacterial Status Performance With Trained vs Untrained Users
A clinical trial, sponsored by Woundchek Laboratories.
- Completed
- Registry status
- 36
- Enrollment target
NCT06560125: Completed study, sponsored by Woundchek Laboratories.
NCT06560125 is a clinical trial that has completed, run by Woundchek Laboratories. The registered enrollment target is 36 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06560125 has completed, sponsored by Woundchek Laboratories.
- COMPLETED
- Registry status
- 36 participants
- Enrollment target
Study Summary
The purpose of this clinical study is to evaluate the performance of WOUNDCHEK™ Bacterial Status (WCBS) with untrained users in diverse CLIA waived locations and trained users and compare the results to those obtained in the study used for De Novo approval (DEN180014). Untrained and trained users are as defined in the FDA guidance document entitled 'Recommendations for Clinical Laboratory Improvement Amendments of 1988 (CLIA) Waiver Applications for Manufacturers of In Vitro Diagnostic Devices' (Feb 2020). The test result will be blinded to the clinician treating the wound. The healing outcome at 12 weeks following the test will be compared for wounds positive vs negative for bacterial protease activity (BPA). Study success criteria will be that the positive likelihood ratio (PLR) of a BPA positive wound being non-healing at 12 weeks for both trained and untrained users will be statistically comparable to the PLR obtained in the study submitted for DEN180014.
Primary Outcome
Complete wound closure
Interventions
- OTHER Standard care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2024-08-01 |
| Est. Completion | 2025-02-14 |
What the finished NCT06560125 record still lists
NCT06560125 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 36 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Standard care is the first listed.
NCT06560125 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06560125 about?
NCT06560125 is a clinical study titled "WOUNDCHEK Bacterial Status Performance With Trained vs Untrained Users". The purpose of this clinical study is to evaluate the performance of WOUNDCHEK™ Bacterial Status (WCBS) with untrained users in diverse CLIA waived locations and trained users and compare the results to those obtained in the study used for De Novo approval (DEN180014). Untrained and trained users ar...
What is the current status of trial NCT06560125?
This trial is currently completed. The enrollment target is 36 participants. The study started on 2024-08-01. Estimated completion is 2025-02-14.
What interventions are being tested in trial NCT06560125?
The interventions under investigation include: Standard care (OTHER).
Who is sponsoring clinical trial NCT06560125?
This trial is sponsored by Woundchek Laboratories, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI